Schmidt Reinhold, Marksteiner Michael, Dal-Bianco Peter, Ransmayr G, Bancher C, Benke T, Wancata J, Fischer P, Leblhuber C F, Psota G, Ackerl M, Alf C, Berek K, Croy A, Delazer M, Fasching P, Frühwald T, Fruhwürth G, Fuchs-Nieder B, Gatterer G, Grossmann J, Hinterhuber H, Iglseder B, Imarhiagbe D, Jagsch C, Jellinger K, Kalousek M, Kapeller P, Ladurner G, Lampl C, Lechner A, Lingg A, Nakajima T, Rainer M, Reisecker F, Spatt J, Walch T, Uranüs M, Walter A
Universitätsklinik für Neurologie, Medizinische Universität Graz,
Neuropsychiatr. 2010;24(2):67-87.
The Austrian Alzheimer Society developed evidence-based guidelines based on a systematic literature search and criteria-guided assessment with subsequent transparent determination of grades of clinical recommendation. The authors evaluated currently available therapeutic approaches for the most common forms of dementia and focused on diagnosis and pharmacological intervention, taking into consideration the situation in Austria. The purpose of these guidelines is the rational and cost-effective use of diagnostic and therapeutic measures in dementing illnesses. Users are physicians and all other providers of care for patients with dementia in Austria.
奥地利阿尔茨海默病协会基于系统的文献检索和标准引导的评估,随后进行临床推荐等级的透明确定,制定了循证指南。作者评估了目前针对最常见痴呆形式的可用治疗方法,并在考虑奥地利国情的情况下,重点关注诊断和药物干预。这些指南的目的是在痴呆症疾病中合理且经济高效地使用诊断和治疗措施。用户为奥地利的医生以及所有其他为痴呆症患者提供护理的人员。